Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch-like protein 32 (KLHL32) is a member of the KLHL family, a group of proteins defined by the presence of BTB/POZ, BACK, and Kelch motifs. KLHL proteins typically act as adaptor proteins for Cullin 3-based E3 ubiquitin ligase complexes, contributing to the selective ubiquitination and degradation of various substrate proteins[1][2]. While many KLHL family members are known to regulate processes such as cytoskeletal organization, gene expression, and cell signaling, the specific biological functions and disease associations of KLHL32 itself have not been clearly characterized in published research to date[1][2]. No small molecules, drugs, or disease biomarker roles have been described for KLHL32. Like other KLHL proteins, it may participate in protein-protein interactions and act as a scaffold within E3 ubiquitin ligase complexes, but direct experimental evidence for KLHL32-specific functions or roles in human disease is currently lacking.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like protein 32 (KLHL32).